Explore
Validate
LearnPA5-42782
antibody from Invitrogen Antibodies
Targeting: N6AMT1
C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-42782 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- N6AMT1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Peptide sequence: MAGENFATPF HGHVGRGAFS DVYEPAEDTF LLLNALEAAA AELAGVEICL
- Concentration
- 0.5 mg/mL
Submitted references DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer.
Sheng X, Wang J, Guo Y, Zhang J, Luo J
Frontiers in oncology 2020;10:616098
Frontiers in oncology 2020;10:616098
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of mouse brain cell lysate using an anti-N6AMT1 polyclonal antibody (Product # PA5-42782).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human NCI-H226 cell lysate using an anti-N6AMT1 polyclonal antibody (Product # PA5-42782).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3 6mA regulates the resistance to Olaparib of MDA-MB-231. The protein expressions of (A) ALKBH1 and (B) N6AMT1 were detected by Western blot; (C, D) IC50 analyzed the changes of drug resistance in each group. ***p < 0.001, n = 3.
